How to apply the personalized medicine in obesity-associated asthma?. (1st September 2020)
- Record Type:
- Journal Article
- Title:
- How to apply the personalized medicine in obesity-associated asthma?. (1st September 2020)
- Main Title:
- How to apply the personalized medicine in obesity-associated asthma?
- Authors:
- Tiotiu, Angelica
Labor, Marina
Nedeva, Denislava
Novakova, Silviya
Oguzulgen, Ipek Kivilcim
Mihaicuta, Stefan
Braido, Fulvio - Abstract:
- ABSTRACT: Introduction: Obesity-associated asthma (OA) is frequently severe, with an increased rate of hospitalizations, numerous comorbidities and low response to corticosteroids. Despite progress in applying for personalized medicine in asthma, no specific recommendations exist for the management of OA. Areas covered: The aim of this review is to summarize recent data about the relationship obesity-asthma, describe clinical characteristics, potential mechanisms involved and possible therapeutic interventions to improve OA outcomes. Extensive research in the PubMed was performed using the following terms: "asthma and obesity" and "obese asthma" in combination with "phenotypes", "airway inflammation", "biomarkers", "lung function", "weight loss", "lifestyle interventions", "therapies" Currently two phenotypes are described. Early-onset atopic asthma is conventional allergic asthma aggravated by the pro-inflammatory properties of adipose tissue in excess, while late-onset non-atopic asthma is due to airway dysfunction as a consequence of the chronic lung compression caused by the obese chest walls. Previous data showed that different therapeutic strategies used in weight loss have a positive impact on OA outcomes. Expert opinion: The presence of a multidisciplinary team (chest physician, nutritionist, exercise physiologist, physiotherapist, psychologist, bariatric surgeon) and the collaboration between different specialists are mandatory to optimize the management and toABSTRACT: Introduction: Obesity-associated asthma (OA) is frequently severe, with an increased rate of hospitalizations, numerous comorbidities and low response to corticosteroids. Despite progress in applying for personalized medicine in asthma, no specific recommendations exist for the management of OA. Areas covered: The aim of this review is to summarize recent data about the relationship obesity-asthma, describe clinical characteristics, potential mechanisms involved and possible therapeutic interventions to improve OA outcomes. Extensive research in the PubMed was performed using the following terms: "asthma and obesity" and "obese asthma" in combination with "phenotypes", "airway inflammation", "biomarkers", "lung function", "weight loss", "lifestyle interventions", "therapies" Currently two phenotypes are described. Early-onset atopic asthma is conventional allergic asthma aggravated by the pro-inflammatory properties of adipose tissue in excess, while late-onset non-atopic asthma is due to airway dysfunction as a consequence of the chronic lung compression caused by the obese chest walls. Previous data showed that different therapeutic strategies used in weight loss have a positive impact on OA outcomes. Expert opinion: The presence of a multidisciplinary team (chest physician, nutritionist, exercise physiologist, physiotherapist, psychologist, bariatric surgeon) and the collaboration between different specialists are mandatory to optimize the management and to apply the personalized medicine in OA. … (more)
- Is Part Of:
- Expert review of respiratory medicine. Volume 14:Number 9(2020)
- Journal:
- Expert review of respiratory medicine
- Issue:
- Volume 14:Number 9(2020)
- Issue Display:
- Volume 14, Issue 9 (2020)
- Year:
- 2020
- Volume:
- 14
- Issue:
- 9
- Issue Sort Value:
- 2020-0014-0009-0000
- Page Start:
- 905
- Page End:
- 915
- Publication Date:
- 2020-09-01
- Subjects:
- Obese-asthma phenotypes -- multidisciplinary team -- personalized medicine
Respiratory organs -- Diseases -- Periodicals
Respiratory organs -- Diseases -- Treatment -- Periodicals
616.2005 - Journal URLs:
- http://www.future-drugs.com/loi/ers ↗
http://www.tandfonline.com/loi/IERX ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/17476348.2020.1780123 ↗
- Languages:
- English
- ISSNs:
- 1747-6348
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9830.066000
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 22635.xml